Sargent Investment Group, LLC Exelixis, Inc. Call Options Transaction History

Sargent Investment Group, LLC

  • $546 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$17.44 - $23.16 $654,000 - $868,500
37,500 Added 75.0%
87,500 $134,000
Q1 2022

May 06, 2022
BUY
$17.03 - $22.67 $510,900 - $680,100
30,000 Added 150.0%
50,000 $190,000
Q3 2020

Nov 12, 2020
BUY
$20.67 - $26.94 $413,400 - $538,800
20,000 New
20,000 $19,000

Others Institutions Holding EXEL

# of Institutions
502
Shares Held
243M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email